[1] |
YANG Caihua, YANG Longna, LI Xiaobo.
Two cases of fetal malformation after exposure to low dose warfarin sodium tablets in early pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1286-1289.
|
[2] |
ZHANG Wenwen, NIE Xiting, XU Huiru, RAN Ye, TIAN Chenglin, YU Shengyuan.
One case of extremely abnormal coagulation caused by warfarin combined with compound paracetamol and amantadine hydrochloride tablets
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1290-1292.
|
[3] |
LIU Tiantian, CAO Junling, ZHANG Yanli, GONG Ying, GU Yuanyuan.
Research progress in enhancing anticoagulant effects of warfarin and the mechanism by traditional Chinese medicine for promoting blood circulation and removing blood stasis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 117-120.
|
[4] |
WEN Dusu, SUN Jianjun, WANG Yi.
Safety and efficacy of participation of pharmacists in warfarin anticoagulation therapy:a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1009-1014.
|
[5] |
XIANG Yunxia, PU Wen, LI Dongfeng, WANG Jie.
Effects of pharmacists' intervention on anticoagulant management of patients treated with warfarin after heart valve replacement
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 545-549.
|
[6] |
CHAI Xiaoli, ZHANG Chen, FENG Qingchun, LIU Huan.
Current medications and influencing factors for senile patients with NVAF
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 302-305.
|
[7] |
GUO Jun, REN Dan, YE Long, ZHAO Rongxiang, WANG Yu, YU Jing.
Spontaneous muscular hemorrhage induced by warfarin tablets in a child
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 339-341.
|
[8] |
JIANG Ruiqi, MEI Shenghui, ZHAO Zhigang.
Research progress in influence of gender difference on drug therapy of common chronic diseases of the cardiovascular system
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1145-1148.
|
[9] |
WU Ting, LYV Xiaoqin.
Drug-induced Liver Injury Caused by Warfarin
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(4): 365-367.
|
[10] |
DONG Min, ZOU Tong, XU Lei, HE Qinghua, PEI Zuowei, WANG Fang.
Effects of Polypharmacy on Long-term Prognosis of Elderly Patients with Coronary Heart Disease and Atrial Fibrillation
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 126-132.
|
[11] |
LI Yu, FAN Huihui, FENG Xiaojun, WANG Yunhong, CHEN Chuantao, ZHANG Lei.
Individualized Anticoagulant Therapy for Warfarin in a Patient with Poor Metabolism
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 939-942.
|
[12] |
BAI Hehe, NIE Xiaojing, XIA Li, ZHAO Meng, WANG Jinping, YAO Yanqin.
Analysis of One Case of Warfarin Related Nephropathy
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 934-938.
|
[13] |
ZHU Mingjing, ZHANG Dandan, YANG Ying, YANG Yue.
Efficacy and Safety of Oral Anticoagulants in Non-valvular Atrial Fibrillation Therapy: A Bayesian Network Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 726-731.
|
[14] |
YANG Wen, WANG Qi.
Analysis of the Clinical Characteristics and Prognosis of 371 Cases of Drug-Induced Liver Injury in Our Hospital
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(5): 293-296.
|
[15] |
YANG Yuhui, LUO Zhurong, ZHENG Weixing, HUANG Mingfang, LIN Yi, CAO Xiaozhi, ZHANG Wenli.
Assessment of Rationality, Safety and Adherence of Dabigatran in Patients with Nonvalvular Atrial Fibrillation
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(12): 705-708.
|